Journal article
In vitro susceptibility of recent Chlamydia trachomatis clinical isolates to the CtHtrA inhibitor JO146
Vanissa A Ong, Amba Lawrence, Peter Timms, Lenka A Vodstrcil, Sepehr N Tabrizi, Kenneth W Beagley, John A Allan, Jane S Hocking, Wilhelmina M Huston
Microbes and Infection | ELSEVIER | Published : 2015
Grants
Awarded by NHMRC Project
Awarded by ARC Linkage Project from The Wesley and Saint Andrews Research Institute
Funding Acknowledgements
The project that collected the clinical isolates that were used in this study was funded by NHMRC Project Grant (APP1023239). The work conducted here to analyse the impact of JO146 on these clinical isolates was funded by ARC Linkage Project LP1102500077 which includes partner funding from The Wesley and Saint Andrews Research Institute. Professor Matt Bogyo (Stanford University) and Dr Joel Tyndall (University of Otago) contributed to the identification of JO146. We wish to thank the ACTS study nurses Ruthy McIver and Karen Worthington, and also acknowledge Marcus Chen, Christopher K Fairley and Anna McNulty for facilitating recruitment in their clinics.